Select Region or Location
Americas
  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • Other Americas
Europe
  • Austria
  • Belgium
  • Bulgaria
  • Croatia/Hrvatska
  • Cyprus
  • Czech Republic
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovak Republic
  • Slovenia
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Kingdom
  • Other Europe
Asia Pacific
  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Korea, Republic of
  • Malaysia
  • New Zealand
  • Philippines
  • Singapore
  • Thailand
  • Vietnam
  • Other Asia Pacific
Africa And Middle East
  • Egypt
  • Israel
  • Other Africa And Middle East
USD
Home Cart Sign in  
Chemical Structure| 141136-83-6 Chemical Structure| 141136-83-6

Structure of TRAP-6
CAS No.: 141136-83-6

Chemical Structure| 141136-83-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

TRAP-6 (PAR-1 agonist peptide), a polypeptide fragment, is a selective protease-activating receptor 1 (PAR1) agonist. TRAP-6 activates human platelets through the thrombin receptor. TRAP-6 is inactive against PAR4.

Synonyms: PAR-1 agonist peptide; Thrombin Receptor Activator Peptide 6; Ser-Phe-Leu-Leu-Arg-Asn

4.5 *For Research Use Only! Not for Human Use. We Do Not Sell to Patients.

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]}{[ size_append_text(item.pr_size, proInfo.prAm, 'list') ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}
    {[ size_append_text(item.pr_size, proInfo.prAm, 'list') ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of TRAP-6

CAS No. :141136-83-6
Formula : C34H56N10O9
M.W : 748.87
SMILES Code : O=C(N[C@@H](CC(C)C)C(N[C@@H](CC(C)C)C(N[C@@H](CCCNC(N)=N)C(N[C@H](C(O)=O)CC(N)=O)=O)=O)=O)[C@@H](NC([C@@H](N)CO)=O)CC1=CC=CC=C1
Synonyms :
PAR-1 agonist peptide; Thrombin Receptor Activator Peptide 6; Ser-Phe-Leu-Leu-Arg-Asn
English Name :(2S,5S,8S,11S,14S,17S)-17-Amino-2-(2-amino-2-oxoethyl)-14-benzyl-5-(3-guanidinopropyl)-18-hydroxy-8,11-diisobutyl-4,7,10,13,16-pentaoxo-3,6,9,12,15-pentaazaoctadecan-1-oic acid
MDL No. :MFCD00238172
InChI Key :HAGOWCONESKMDW-FRSCJGFNSA-N
Pubchem ID :9831933

Safety of TRAP-6

Related Pathways of TRAP-6

GPCR

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Human pulmonary artery endothelial cells (HPAECs) 50 ng/ml 2 hours To investigate the effect of TRAP-6 on endothelial barrier function under mechanical stretch and PC treatment. Results showed that TRAP-6 exacerbated stretch-induced barrier disruption, while PC enhanced barrier protection via a KRIT1-dependent mechanism. Am J Respir Cell Mol Biol. 2015 Dec;53(6):834-43.
HESC-derived platelets 40 μM To evaluate the in vitro functionality of hESC-derived platelets upon stimulation with ADP and TRAP-6 Stem Cell Res Ther. 2024 Nov 28;15(1):454.
Human platelets 10 μmol/l 30 minutes To evaluate the effect of dapagliflozin on platelet CD62P expression, results showed dapagliflozin reduced the percentage of CD62P-positive platelets after TRAP-6 stimulation. Diabetologia. 2021 Aug;64(8):1834-1849.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6J mice Two-hit model of ALI caused by high tidal volume mechanical ventilation and TRAP6 injection Intratracheal injection 1.5 × 10−5 mol/kg Single injection, lasting 4 hours To investigate the effect of TRAP-6 on lung vascular permeability under high tidal volume mechanical ventilation. Results showed that TRAP-6 exacerbated lung vascular leak and injury, and KRIT1 deficiency further enhanced these effects and attenuated the protective effects of PC. Am J Respir Cell Mol Biol. 2015 Dec;53(6):834-43.
Mice Crescentic glomerulonephritis model Subcutaneous injection 2 mg/kg Twice daily for 10 days To evaluate the effect of TRAP-6 on glomerular inflammation and injury via PAR-1 activation. Results showed that TRAP-6 significantly increased glomerular crescent formation, fibrin deposition, and inflammatory cell infiltration, indicating that PAR-1 activation exacerbates glomerular inflammation and injury. J Exp Med. 2000 Feb 7;191(3):455-62

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.34mL

0.27mL

0.13mL

6.68mL

1.34mL

0.67mL

13.35mL

2.67mL

1.34mL

References

 

Historical Records

Categories